Rallybio Corp (RLYB) Financials

$16.94

$0.25 (1.50%)

As on 02-Sep-2026 16:00EDT

Market cap

$89 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

2.1

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.65	0.86	0.64	--	--	--
Cost of Revenue	7.80	0.09	39.51	0.15	0.17	0.11
Gross Profit	-7.16	0.77	-38.87	-0.15	-0.17	-0.11
Operating Expenses	16.57	28.83	21.63	78.93	67.88	45.65
Operating Profit (EBIT)	-23.72	-28.06	-60.50	-78.93	-67.88	-45.65
Other Income	--	--	--	--	1.02	-1.36
Profit before Tax	46.88	-8.98	-57.78	-74.56	-66.65	-47.01
Provision for Tax	1.32	--	-2.24	-2.04	-1.08	1.50
Profit after Tax (Net Income)	45.55	-8.98	-57.78	-74.56	-66.65	-47.01
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-66.65	-45.51

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	94.50	57.96	61.65	106.18	169.32	175.60
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.08	0.21	0.17	0.37	0.03
Current Liabilities	3.57	4.22	6.24	9.26	10.74	6.55
Total Liabilities	101.63	62.26	68.11	115.62	180.44	182.19

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.81	1.01	0.27	0.83	0.94	1.32
Current Assets	97.25	61.25	67.84	114.79	179.50	180.87
Total Assets	101.63	62.26	68.11	115.62	180.44	182.19
Total Debt*	--	0.18	0.15	0.39	0.56	--
Net Current Assets	93.69	57.03	61.60	105.53	168.75	174.32

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-29.81	-49.28	-60.27	-57.28	-45.53
Cash Flow from Investing Activities	--	47.27	33.49	27.66	-112.17	-2.33
Cash from Financing Activities	--	0.02	5.20	0.14	51.08	82.97
Net Cash Inflow / Outflow	--	--	--	--	-118.38	35.10

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	7.81	-1.70	-10.35	-14.68	-15.01	-12.63
Cash EPS ($)	--	-1.68	-10.33	-14.65	-14.98	-12.60
Adjusted Book Value ($)	--	10.97	11.04	20.90	38.14	47.16
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-5.64	-8.83	-11.86	-12.90	-12.23
Free Cash Flow per Share ($)	--	-5.64	-8.83	-11.87	-12.92	-12.32

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-14.97	-68.62	-53.94	-38.59	-30.17
ROE (%)	59.76	-15.01	-68.85	-54.13	-38.65	-30.17
ROA (%)	57.78	-13.77	-62.89	-50.37	-36.76	-29.02
EBIT Margin (%)	4,167.03	-3,270.86	-9,511.95	--	--	--
Net Margin (%)	7,051.24	-1,046.39	-9,084.12	--	-6,560.43	3,469.59
Cash Profit Margin (%)	0.16	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-15.11	0.35	--	--	--	--
EBIT Growth (%)	162.02	53.61	23.36	-16.27	-49.20	-79.81
Net Profit Growth (%)	209.36	84.46	22.52	-11.87	-41.78	-77.76
EPS Growth (%)	204.82	0.84	0.29	0.02	-0.19	-0.33
Book Value Growth (%)	98.75	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	2.10	-0.40	-0.09	-0.16	-0.44	-0.76
Price / Book Value	0.94	0.06	0.09	0.11	0.17	0.20
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.41	1.82	0.99	1.24	2.06	3.08
Close Price ($)	16.00	5.49	7.68	19.12	52.56	76.32
High Price ($)	17.57	8.64	27.68	79.00	127.12	206.24
Low Price ($)	2.55	1.76	6.73	13.76	36.32	68.88
Market Cap ($ Cr)	89.27	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.00	0.00	0.00	--
Short term debt to equity ratio	--	0.00	0.00	0.00	0.00	--
Current Ratio	27.26	14.50	10.87	12.39	16.71	27.61
Quick Ratio	27.26	--	--	--	--	--
Interest Coverage	--	--	--	--	-29.45	-4,549.80

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.01	0.01	0.01	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	801.96	5.80	2,544.58	1,877.65	3,655.85
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.